EPTMF (Epitomee Medical) Ending Cash Position: $13.65 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EPTMF Epitomee Medical Ltd EPTMF
29 GF Score
Price $0.99
! 3 Warning Signs
View Full Analysis

What is Epitomee Medical Ending Cash Position?

Epitomee Medical EPTMF 29 Ending Cash Position is $13.65 Mil as of Dec. 2025. GuruFocus rates EPTMF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Epitomee Medical's Ending Cash Position for the quarter that ended in Dec. 2025 was $13.65 Mil.

Epitomee Medical's quarterly Ending Cash Position increased from Dec. 2024 ($16.57 Mil) to Jun. 2025 ($18.25 Mil) but then declined from Jun. 2025 ($18.25 Mil) to Dec. 2025 ($13.65 Mil).

Epitomee Medical's annual Ending Cash Position increased from Dec. 2023 ($15.63 Mil) to Dec. 2024 ($16.57 Mil) but then declined from Dec. 2024 ($16.57 Mil) to Dec. 2025 ($13.65 Mil).

Epitomee Medical Ending Cash Position Related Terms

Epitomee Medical Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Epitomee Medical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epitomee Medical Ending Cash Position Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 64.31 35.95 15.63 16.57 13.65

Epitomee Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.63 12.50 16.57 18.25 13.65
EPTMF
29GF Score
Epitomee Medical Ltd EPTMF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epitomee Medical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Epitomee Medical's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=16.569+-2.921
=13.65

Epitomee Medical's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=18.251+-4.603
=13.65

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $13.65 Mil mean?
Epitomee Medical (EPTMF) has a Ending Cash Position of $13.65 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Epitomee Medical and its competitors.
Is Epitomee Medical's Ending Cash Position too high?
Epitomee Medical's current Ending Cash Position is $13.65 Mil. Overall, Epitomee Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's Ending Cash Position compare to ABT and SYK?
Epitomee Medical's Ending Cash Position of $13.65 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Epitomee Medical and its competitors. Epitomee Medical's current Ending Cash Position is $13.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current Ending Cash Position of $13.65 Mil. The current Ending Cash Position is $13.65 Mil. Epitomee Medical's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current Ending Cash Position is $13.65 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epitomee Medical Business Description

Other Exchanges EPIT:Israel
Address Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
29GF Score

Get the complete analysis for EPTMF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price